• Publications
  • Influence
[Development of resistance to difuracil (PAP-49) in bacteria and its activity in combination with other antibacterial drugs].
: Possible increasing of resistance to difuracil or N-(5-nitrofurfuryliden)-5-nitrofuran-2-(N'-acetyl) carboxamidohydrazon (PAP-49) in Staphylococcus sp., Streptococcus sp. and Escherichia coli wasExpand
[Therapeutic effectiveness of furazolidone and difuracil (PAP-49) in experimental staphylococcal and Escherichia septicemia].
It was shown in the models of staphylococcal and Coli septicemia of albino mice that by its therapeutic efficacy difuracil was 1.3 times more active as furazolidone and by 1-2 days earlier eradicated the pathogens in the host. Expand